BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 31215527)

  • 1. Proliferation of Ovarian Granulosa Cells in Polycystic Ovarian Syndrome Is Regulated by MicroRNA-24 by Targeting Wingless-Type Family Member 2B (WNT2B).
    Yuanyuan Z; Zeqin W; Xiaojie S; Liping L; Yun X; Jieqiong Z
    Med Sci Monit; 2019 Jun; 25():4553-4559. PubMed ID: 31215527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of MiR-324-3p in polycystic ovary syndrome (PCOS) via targeting WNT2B.
    Jiang YC; Ma JX
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3286-3293. PubMed ID: 29917177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor.
    Wu YX; Lin YS; Li SC; Yao X; Cheng M; Zhu L; Liu HY
    Reprod Biol Endocrinol; 2021 Nov; 19(1):170. PubMed ID: 34814928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circ_0043532 regulates miR-182/SGK3 axis to promote granulosa cell progression in polycystic ovary syndrome.
    Xu L; Xiong F; Bai Y; Xiao J; Zhang Y; Chen J; Li Q
    Reprod Biol Endocrinol; 2021 Nov; 19(1):167. PubMed ID: 34740363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of microRNA-19b promotes ovarian granulosa cell proliferation by targeting IGF-1 in polycystic ovary syndrome.
    Zhong Z; Li F; Li Y; Qin S; Wen C; Fu Y; Xiao Q
    Mol Med Rep; 2018 Apr; 17(4):4889-4898. PubMed ID: 29363717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-130b-3p is high-expressed in polycystic ovarian syndrome and promotes granulosa cell proliferation by targeting SMAD4.
    Bao D; Li M; Zhou D; Zhuang C; Ge Z; Wei Q; Zhang L
    J Steroid Biochem Mol Biol; 2021 May; 209():105844. PubMed ID: 33582305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-200b and microRNA-200c are up-regulated in PCOS granulosa cell and inhibit KGN cell proliferation via targeting PTEN.
    He T; Sun Y; Zhang Y; Zhao S; Zheng Y; Hao G; Shi Y
    Reprod Biol Endocrinol; 2019 Aug; 17(1):68. PubMed ID: 31421682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-16 Promotes Ovarian Granulosa Cell Proliferation and Suppresses Apoptosis Through Targeting PDCD4 in Polycystic Ovarian Syndrome.
    Fu X; He Y; Wang X; Peng D; Chen X; Li X; Wan Q
    Cell Physiol Biochem; 2018; 48(2):670-682. PubMed ID: 30025387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome.
    Jiang L; Huang J; Li L; Chen Y; Chen X; Zhao X; Yang D
    J Clin Endocrinol Metab; 2015 May; 100(5):E729-38. PubMed ID: 25695884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-141-3p targets DAPK1 and inhibits apoptosis in rat ovarian granulosa cells.
    Li D; Xu D; Xu Y; Chen L; Li C; Dai X; Zhang L; Zheng L
    Cell Biochem Funct; 2017 Jun; 35(4):197-201. PubMed ID: 28543175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circ_FURIN knockdown assuages Testosterone-induced human ovarian granulosa-like tumor cell disorders by sponging miR-423-5p to reduce MTM1 expression in polycystic ovary syndrome.
    Xu X; Guan R; Gong K; Xie H; Shi L
    Reprod Biol Endocrinol; 2022 Feb; 20(1):32. PubMed ID: 35177076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-646 inhibits the proliferation of ovarian granulosa cells via insulin-like growth factor 1 (IGF-1) in polycystic ovarian syndrome (PCOS).
    Lu J; Xuan F; Chen A; Jin R; Zhou W; Ye Y; Ren Y
    Endokrynol Pol; 2023; 74(3):305-314. PubMed ID: 37155307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional Characterization of MicroRNA-27a-3p Expression in Human Polycystic Ovary Syndrome.
    Wang M; Sun J; Xu B; Chrusciel M; Gao J; Bazert M; Stelmaszewska J; Xu Y; Zhang H; Pawelczyk L; Sun F; Tsang SY; Rahman N; Wolczynski S; Li X
    Endocrinology; 2018 Jan; 159(1):297-309. PubMed ID: 29029022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-3188 Regulates proliferation and apoptosis of granulosa cells by targeting KCNA5 in the polycystic ovary syndrome.
    Zhou S; Xia L; Chen Y; Guo W; Hu J
    Acta Biochim Pol; 2021 Feb; 68(1):83-89. PubMed ID: 33533580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-145 Negatively Regulates Cell Proliferation Through Targeting IRS1 in Isolated Ovarian Granulosa Cells From Patients With Polycystic Ovary Syndrome.
    Cai G; Ma X; Chen B; Huang Y; Liu S; Yang H; Zou W
    Reprod Sci; 2017 Jun; 24(6):902-910. PubMed ID: 27799458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 inhibits ovarian granulosa cell proliferation by targeting SNHG7 in premature ovarian failure with polycystic ovary syndrome.
    Aldakheel FM; Abuderman AA; Alduraywish SA; Xiao Y; Guo WW
    J Reprod Immunol; 2021 Aug; 146():103328. PubMed ID: 34020163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-338-3p Enhances Ovarian Cancer Cell Sensitivity to Cisplatin by Downregulating WNT2B.
    Niu Q; Liu Z; Gao J; Wang Q
    Yonsei Med J; 2019 Dec; 60(12):1146-1156. PubMed ID: 31769245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-9119 regulates cell viability of granulosa cells in polycystic ovarian syndrome via mediating Dicer expression.
    Ding Y; He P; Li Z
    Mol Cell Biochem; 2020 Feb; 465(1-2):187-197. PubMed ID: 31894528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA let-7i inhibits granulosa-luteal cell proliferation and oestradiol biosynthesis by directly targeting IMP2.
    Xu X; Shen HR; Yu M; Du MR; Li XL
    Reprod Biomed Online; 2022 May; 44(5):803-816. PubMed ID: 35339367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of circ-FURIN suppresses the proliferation and induces apoptosis of granular cells in polycystic ovary syndrome via miR-195-5p/BCL2 axis.
    Chen Y; Miao J; Lou G
    J Ovarian Res; 2021 Nov; 14(1):156. PubMed ID: 34784951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.